Trending storyDeveloping
With new Omvoh analyses, Lilly argues 'higher bar' for IBD treatment is within reach - Fierce Pharma
1 report1 sourceupdated 18 hours ago
Start here
No synthesis yet — start with the coverage timeline below.
Coverage timeline
Follow the coverage to see the different angles.
Heat trend for this story
Not enough continuous observation yet to draw a trend.